Cover Image
Market Research Report
Product code 
1081043

Cell Culture Media Market: Current Analysis and Forecast (2021-2027)

Published: | UnivDatos Market Insights Pvt Ltd | 229 Pages | Delivery time: 1-2 business days

Price

Back to Top
Cell Culture Media Market: Current Analysis and Forecast (2021-2027)
Published: April 1, 2022
UnivDatos Market Insights Pvt Ltd
Content info: 229 Pages
Delivery time: 1-2 business days
  • Description
  • Table of Contents

Global Cell Culture Media Market is anticipated to grow with an elevated CAGR of around 12% over the forecast period (2021-2027). Cell culture media usually consist of an appropriate source of energy and compounds which regulate the cell cycle. It contains different nutrients that help in the growth, proliferation, maintenance, and storage of microbial and other cell types including stem cells. A wide range of cell culture media is available in the market that facilitates the growth of different types of cells.

With rapid technological advancement in cell biology and rising investment in research & development of pharmaceutical & biotechnology companies, the cell culture media market is witnessing an uptick all over the globe. For instance, the Pharmaceutical Research and Manufacturers of America (PhRMA) trade group represents the leading biopharmaceutical research companies in the United States. In 2019, the research and development (R&D) expenditure of its member companies reached USD 83 billion worldwide, up from USD 79.6 billion in 2018. Furthermore, the growing focus on cell culture technology for developing monoclonal antibodies and support by the government for research and funding is propelling the growth of this market.

Furthermore, the cell culture media market is anticipated to grow on account of the rapid progress in biopharmaceuticals, oncology, and stem cell research. Cell culture plays a vital role in vaccine production and cell culture technology has been used to produce vaccines for chicken pox, polio, smallpox, hepatitis, etc. Also, cell culture-based vaccine production is far more efficient and offers many advantages over traditional manufacturing methods such as shortened lead-time and the capability to produce vaccines in larger quantities. Thus, recent years have witnessed an increased demand for cell-based vaccines, resulting in efforts by major industry players to capitalize on the opportunities provided. Thereby, boosting the growth of the cell culture media market globally. For example, in Feb 2020, Seqirus received US FDA approval for AUDENZ, a cell-based Influenza A (H5N1) Monovalent Vaccine for individuals aged six months and older. Thermo Fisher Scientific, Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Hi-Media Laboratories Pvt. Ltd., Merck KGaA, Corning Incorporated, Sartorius AG, Fujifilm Holdings Corporation, Lonza Group Ltd, Caisson Laboratories Inc., are some of the prominent players operating in the cell culture media market. Several M&As along with partnerships have been undertaken by these players to facilitate customers with cell culture media.

Insights Presented in the Report

"Amongst Type, serum-free media segment holds the major share"

Based on type, the cell culture media market is segmented into lysogeny broth, chemically defined media, classical media, serum-free media, specialty media, stem cell media, and others. The serum-free media segment accounted for a significant market share in 2020 and it is estimated that it will grow rapidly during the projected timeframe. The growth of this segment can be attributed to the advantages of serum-free media over other types of media, including consistent performance, increased growth & productivity, better control over physiological responsiveness, and reduced risk of contamination by serum-borne adventitious agents in cell culture.

"Amongst Application, biopharmaceuticals segment holds the major share"

Based on application, the cell culture media market is segmented into cancer research, biopharmaceuticals, regenerative medicine & tissue engineering, and diagnostics. The biopharmaceuticals segment occupied the major share of the cell culture media market in 2020 and it is expected to grow with a substantial CAGR in the upcoming years. The growth of this segment is attributed to the commercial expansion of major pharmaceutical and biotechnology companies and the growing demand for various biopharma products such as mAbs. Furthermore, the growing regulatory approvals to produce cell culture-based vaccines is also one of the prominent factors contributing to the growth of this segment.

"Amongst End-Users, pharmaceutical & biotechnology companies segment holds the major share"

Based on end-users, the market is fragmented into pharmaceutical & biotechnology companies, hospitals & diagnostic laboratories, research & academic institutes, and others. In 2020, the pharmaceutical & biotechnology companies segment grabbed a considerable market share, and it is expected to grow at a significant CAGR during the forecast period owing to the rising prevalence of various infectious diseases and increasing research and development activities by biotechnology and pharmaceutical companies. For example, In 2019, Cidara Therapeutics Inc., a biotechnology company focused on developing novel anti-infective CB-012, its Cloudbreak antiviral Fc-conjugate (AVC) candidate for influenza. Thus, these clinical trials are expected to increase the procurement of culture media for performing clinical tests of various drug molecules.

"North America represents one of the largest markets of cell culture media market"

For a better understanding of the market dynamics of the cell culture media market, a detailed analysis was conducted for different regions across the globe including North America (the U.S, Canada, and the Rest of North America), Europe (Germany, France, Spain, United Kingdom, Italy, and Rest of Europe), Asia-Pacific (China, India, Australia, Japan, and Rest of APAC), Rest of World has been conducted. North America constitutes a major market for the cell culture media market industry and generated revenue of USD XX Million in 2020 owing to strong healthcare infrastructure and growing adoption of advanced cell culture technology in the region.

Reasons to buy this report:

The study includes market sizing and forecasting analysis validated by authenticated key industry experts

The report presents a quick review of overall industry performance at one glance

The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments

Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry

The study comprehensively covers the market across different segments

Deep dive regional level analysis of the industry

Customization Options:

The global cell culture media market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.

Product Code: UMHE21785

TABLE OF CONTENTS

1 MARKET INTRODUCTION

  • 1.1 Market Definitions
  • 1.2 Objective of the Study
  • 1.3 Limitation
  • 1.4 Stake Holders
  • 1.5 Currency Used in Report
  • 1.6 Scope of the Global Cell Culture Media Study

2 RESEARCH METHODOLOGY OR ASSUMPTION

  • 2.1 Research Methodology for the Global Cell Culture Media Market
    • 2.1.1 Main Objective of the Global Cell Culture Media Market

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 COVID-19 IMPACT

6 GLOBAL CELL CULTURE MEDIA MARKET REVENUE

7 MARKET INSIGHTS BY POLYMER TYPE

  • 7.1 Lysogeny Broth
  • 7.2 Chemically Defined Media
  • 7.3 Classical Media
  • 7.4 Serum-free Media
  • 7.5 Specialty Media
  • 7.6 Stem Cell Media
  • 7.7 Others

8 MARKET INSIGHTS BY APPLICATION

  • 8.1 Cancer Research
  • 8.2 Biopharmaceuticals
  • 8.3 Regenerative Medicine & Tissue Engineering
  • 8.4 Diagnostics
  • 8.5 Drug Development
  • 8.6 Others

9 MARKET INSIGHTS BY END-USERS

  • 9.1 Pharmaceutical & Biotechnology Companies
  • 9.2 Hospitals & Diagnostic Laboratories
  • 9.3 Research & Academic Institutes
  • 9.4 Others

10 MARKET INSIGHTS BY REGION

  • 10.1 NORTH AMERICA CELL CULTURE MEDIA MARKET
    • 10.1.1 United States
    • 10.1.2 Canada
    • 10.1.3 Rest of North America
  • 10.2 EUROPE CELL CULTURE MEDIA MARKET
    • 10.2.1 Germany
    • 10.2.2 France
    • 10.2.3 United Kingdom
    • 10.2.4 Spain
    • 10.2.5 Italy
    • 10.2.6 Rest of Europe
  • 10.3 ASIA PACIFIC CELL CULTURE MEDIA MARKET
    • 10.3.1 China
    • 10.3.2 Japan
    • 10.3.3 India
    • 10.3.4 Australia
    • 10.3.5 Rest of Asia Pacific
  • 10.4 REST OF THE WORLD CELL CULTURE MEDIA MARKET

11 CELL CULTURE MEDIA MARKET DYNAMICS

  • 11.1 Market Drivers
  • 11.2 Market Challenges
  • 11.3 Impact Analysis

12 CELL CULTURE MEDIA MARKET OPPORTUNITIES

13 CELL CULTURE MEDIA MARKET TRENDS & INSIGHTS

14 LEGAL & REGULATORY FRAMEWORK

15 DEMAND AND SUPPLY SIDE ANALYSIS

  • 15.1 Demand Side Analysis
  • 15.2 Supply Side Analysis
    • 15.2.1 Top Product Launches
    • 15.2.2 Top Business Partnerships
    • 15.2.3 Top Merger & Acquisitions

16 VALUE CHAIN ANALYSIS

17 COMPETITIVE SCENARIO

  • 17.1 Porter's Five forces analysis
    • 17.1.1 Bargaining power of Supplier
    • 17.1.2 Bargaining power of Buyer
    • 17.1.3 Industry Rivalry
    • 17.1.4 Availability of Substitute
    • 17.1.5 Threat of new Entrants
  • 17.2 Competitive Landscape
    • 17.2.1 Company Shares, By Revenue

18 COMPANY PROFILED

  • 18.1 Thermo Fisher Scientific, Inc.
    • 18.1.1 Key Facts
    • 18.1.2 Business Description
    • 18.1.3 Key Product/Services Offerings
    • 18.1.4 Growth Strategy
    • 18.1.5 SWOT Analysis
    • 18.1.6 Key Financials
      • 18.1.6.1 Revenue Split
      • 18.1.6.2 Financial Overview of Thermo Fisher Scientific, Inc.
    • 18.1.7 Recent Developments
      • 18.1.7.1 Product Launch
      • 18.1.7.2 Partnerships
      • 18.1.7.3 Business Expansion and Investments
      • 18.1.7.4 Merger and Acquisition
  • 18.2 Becton, Dickinson and Company
  • 18.3 Bio-Rad Laboratories, Inc.
  • 18.4 Hi Media Laboratories Pvt. Ltd.
  • 18.5 Merck KGaA
  • 18.6 Corning Incorporated
  • 18.7 Sartorius AG
  • 18.8 Fujifilm Holdings Corporation
  • 18.9 Lonza Group Ltd
  • 18.10 Caisson Laboratories Inc.

19 DISCLAIMER